Glaucoma Surgery in Gurgaon

Glaucoma surgery is not the starting point. But when it becomes necessary, the decision about which surgery, and when, shapes how much vision you protect for the rest of your life.

This page explains glaucoma surgery from a patient’s perspective. It covers what makes surgery necessary, how a glaucoma specialist decides between different options, what each procedure involves, and what recovery and long-term follow-up actually look like. It is written for patients in Gurgaon and across Delhi NCR who are considering surgery, have been referred for a procedure, or want to understand whether surgery is the right next step.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. She performs the full spectrum of glaucoma surgery in Gurgaon and manages all surgical patients personally through their postoperative course. She is rated 5 stars across 1,500+ patient reviews on Google.

When Is Glaucoma Surgery Necessary?

Most glaucoma is managed first with eye drops, or/ and with laser treatment. Surgery becomes necessary when these are insufficient to protect the optic nerve over the long term.

Specifically, surgery is considered when:

Pressure is not reaching target despite maximum tolerated medication. Every glaucoma patient has an individual target eye pressure, the level likely to keep their disease stable over their lifetime. When drops and laser cannot reliably achieve this, surgery is the next step.

Disease is progressing despite treatment. If visual field tests or OCT scans show continued optic nerve damage despite apparently controlled pressure, the current treatment is not enough.

Drop burden is unsustainable. Multiple drops, multiple times a day, with side effects affecting the ocular surface and quality of life; surgery that reduces or eliminates drops can meaningfully improve a patient’s daily life.

Advanced glaucoma at presentation. Patients presenting late with significant damage need pressure lowered substantially and reliably. Surgery achieves this more consistently than drops alone.

Angle closure. Certain types of glaucoma involving a closed or narrow drainage angle require surgical intervention as part of the treatment plan.

One important principle: surgery is not always a last resort. In patients with advanced disease, rapid progression, or high target pressures that drops cannot reach, surgery earlier in the course of treatment, rather than later, often leads to better long-term outcomes.

Have an emergency/quick query

WhatsApp +91 98187 00269

Get an appointment now

Call +91 88826 38735, +91 98187 00269

Understanding Glaucoma Surgery: What It Actually Does

All glaucoma surgery works by one of two mechanisms: improving drainage of fluid out of the eye, or reducing production of fluid inside the eye. The goal is always the same, to lower intraocular pressure to a level that protects the optic nerve from further damage.

It is important to understand what surgery does not do: it does not restore vision already lost to glaucoma. Damage to the optic nerve from glaucoma is irreversible. Surgery protects the vision you have. This is why the decision about timing matters — surgery at the right moment in the disease course protects more vision than surgery delayed too long.


Types of Glaucoma Surgery

Trabeculectomy vs MIGS: How the Choice Is Made

Patients and referring doctors frequently ask this question, and the answer is never one-size-fits-all. Both procedures lower intraocular pressure. The difference lies in how much pressure reduction is needed, how much surgical risk is acceptable, and what the patient’s disease looks like over the long term.

MIGS offers a gentler reduction in pressure, typically bringing pressure down by 20–30% from baseline, with a significantly lower risk profile and faster recovery. It is the right choice when modest pressure reduction is sufficient to protect the optic nerve, particularly in mild to moderate disease, and especially when cataract surgery is being done at the same time.

Trabeculectomy offers deeper, more sustained pressure reduction, often 30–50% from baseline, sometimes more, and remains the gold standard when the optic nerve needs pressure brought to very low levels to survive. The trade-off is a more demanding postoperative course and a higher risk of complications that require active management.

The decision between them is not simply about severity. A patient with moderate glaucoma who is young, has a low target pressure, and has decades of disease ahead may be better served by trabeculectomy now rather than MIGS that proves insufficient in five years. An older patient with similar pressure but less lifetime risk may do very well with MIGS combined with cataract surgery and avoid a more complex procedure entirely.

This is precisely why the surgical decision requires a subspecialist assessment, not a formula, but a careful weighing of individual factors including age, disease stage, rate of progression, target pressure, conjunctival health, and the patient’s capacity to manage postoperative follow-up.

If you have been quoted one procedure and are uncertain whether it is the right choice for you, a structured glaucoma second opinion before proceeding is entirely reasonable.

Minimally Invasive Glaucoma Surgery (MIGS)

MIGS is a family of newer surgical procedures that lower intraocular pressure through very small incisions, with a significantly better safety profile than traditional glaucoma surgery. They are typically performed under local anaesthesia, often at the same time as cataract surgery, and recovery is faster.

Who is MIGS suitable for?

MIGS is best suited to patients with mild to moderate glaucoma who need pressure lowered but do not yet need the substantial pressure reduction that trabeculectomy provides. It is particularly valuable in patients who also need cataract surgery — combining both procedures reduces surgical burden, often lowers pressure meaningfully, and can reduce dependence on drops.

MIGS is also appropriate for patients who want to reduce drop burden, who have early disease that is progressing despite maximum tolerated medical therapy, or for whom the risks of trabeculectomy outweigh the benefits at that stage of disease.

How does MIGS work?

Different MIGS procedures work through different mechanisms. Some — like the iStent or Hydrus — improve the eye’s natural drainage pathway by placing a tiny implant to bypass the trabecular meshwork and allow fluid to drain more freely into Schlemm’s canal. Others, like the Kahook Dual Blade or Trabectome, remove part of the trabecular meshwork. The XEN gel stent creates a new drainage pathway into the subconjunctival space, similar in principle to trabeculectomy but through a smaller, less invasive approach.

What MIGS cannot do is achieve the very low pressures that trabeculectomy reliably produces. For patients with advanced glaucoma, significant optic nerve damage, or disease that requires pressure in the low teens or single digits, MIGS is usually insufficient as a standalone procedure.

The combined cataract and MIGS procedure

When a patient has both cataract and glaucoma, combining phacoemulsification (cataract removal) with a MIGS procedure is often the most logical choice. Cataract surgery itself lowers eye pressure modestly in many patients, and adding a MIGS procedure at the same time amplifies this effect — often allowing reduction or elimination of drops post-operatively with a single recovery period.


Selective Laser Trabeculoplasty (SLT)

While not a surgical procedure in the traditional sense, SLT deserves mention here because it sits between drops and surgery in the treatment pathway. It uses a laser applied to the drainage angle to stimulate improved outflow. It is effective as a first-line treatment or adjunct, repeatable, and does not preclude future surgery. For appropriate patients — particularly those with early to moderate open-angle glaucoma — SLT can delay or reduce the need for surgery.

Dr Bhartiya is a glaucoma specialist with extensive experience in risk-stratification and longitudinal glaucoma care, including hundreds of SLT and LPI laser procedures.


Trabeculectomy

Trabeculectomy remains the most effective and most extensively studied glaucoma surgery available. It has been the gold standard surgical procedure for over 50 years and, when performed well and followed up carefully, remains unmatched in its ability to achieve sustained low intraocular pressure.

What does trabeculectomy involve?

The surgery creates a new drainage pathway — a small flap in the wall of the eye (the sclera) through which aqueous fluid can drain from inside the eye to just beneath the conjunctiva, forming a small reservoir called a bleb. Fluid is then gradually absorbed from the bleb, lowering intraocular pressure.

An antifibrotic agent — typically Mitomycin C — is applied during surgery to reduce scarring, which is the main cause of trabeculectomy failure over time. The concentration used, and the duration of application, are carefully calibrated to the individual patient.

Who needs trabeculectomy?

Trabeculectomy is indicated for patients with moderate to advanced glaucoma who need substantial and sustained pressure reduction — pressures that MIGS cannot reliably achieve. It is also the appropriate choice when:

    • Disease is advanced and pressure needs to reach very low levels

    • Prior MIGS has been insufficient

    • Progression is rapid and the optic nerve is at high risk

    • The patient is relatively young with decades of disease ahead

In experienced hands, trabeculectomy achieves pressure reduction of 30–50% from baseline, often eliminating the need for drops entirely, at least in the medium term.

What are the risks of trabeculectomy?

Trabeculectomy is effective, but it is not a simple procedure. The risks include hypotony (pressure that drops too low), bleb-related complications, infection (blebitis or endophthalmitis — rare but serious), cataract formation, and the need for further intervention if the bleb scars over. These risks are why trabeculectomy requires careful patient selection, meticulous surgical technique, and close postoperative follow-up — particularly in the first weeks after surgery.

This is also why surgical experience matters. Trabeculectomy outcomes are directly related to surgeon experience and the quality of postoperative management. A bleb that starts to fail can often be rescued with timely intervention — but only if the surgeon knows what to look for and acts promptly.


Tube Shunt Surgery (Glaucoma Drainage Devices)

For patients in whom trabeculectomy has failed, or is likely to fail, tube shunts — such as the Ahmed Glaucoma Valve or Baerveldt implant — provide an alternative drainage pathway. A small silicone tube is implanted in the eye, connected to a plate placed on the surface of the eye under the conjunctiva. Fluid drains through the tube to the plate, where it is absorbed.

Tube shunts are used in:

    • Refractory glaucoma where prior trabeculectomy has failed

    • Eyes with severe scarring that makes trabeculectomy unlikely to succeed

    • Neovascular glaucoma

    • Eyes that have had multiple previous surgeries

    • Certain complex secondary glaucomas

Tube surgery is longer and more involved than trabeculectomy, but it is a valuable and often vision-saving option for patients with complex disease.


Cyclodestructive Procedures

In cases where other surgical options are not suitable, cyclodestructive procedures are an option. This includes advanced disease with limited visual potential, or patients who are not candidates for incisional surgery. The ciliary body (which produces aqueous fluid) is treated to reduce fluid production. the most commonly used technique is Diode laser cyclophotocoagulation (CPC). It is not a first-choice procedure in eyes with good visual potential, but has an important role in selected cases.


How Is the Right Surgery Chosen?

This is the question patients ask most often, when talking about glaucoma surgery in Gurgaon. The honest answer is that there is no formula. The right surgery depends on:

The severity of glaucoma. Mild disease with modest pressure reduction needed points toward MIGS. Advanced disease requiring very low pressures points toward trabeculectomy. Complex, refractory disease may need a tube.

The patient’s age. A 45-year-old with glaucoma needs a solution that will last decades. A 78-year-old with the same pressure may have very different lifetime risk. Age changes the calculus significantly.

The state of the conjunctiva. Trabeculectomy and tube surgery both require healthy conjunctival tissue. Prior eye surgery, prolonged use of certain drops, or previous failed blebs can compromise this, and must be accounted for in surgical planning.

Whether cataract surgery is also needed. If yes, combining with MIGS is often the most efficient path. If not, the options broaden.

The patient’s ability to comply with postoperative care. Trabeculectomy in particular requires careful follow-up in the first weeks: bleb management, suture lysis, monitoring for hypotony. A patient who cannot attend frequent follow-up appointments in the early postoperative period may be better served by a procedure with a less demanding recovery.

The surgeon’s experience with each procedure. Outcomes in glaucoma surgery are strongly surgeon-dependent. The right surgery performed by an experienced surgeon with careful follow-up is always preferable to a theoretically ideal procedure performed by someone who does it infrequently.


What to Expect: Before, During, and After Surgery

Before Surgery

You will have a detailed preoperative assessment reviewing your glaucoma history, current medications, ocular surface health, and systemic health. The surgical plan, which procedure, whether to combine with cataract surgery, antifibrotic use, and anaesthesia approach, will be discussed fully. You will understand exactly what is planned and why.

Certain glaucoma drops may be continued or adjusted before surgery. Blood thinners may need to be paused in consultation with your physician.

The Day of Surgery

Most glaucoma surgeries are performed under local anaesthesia with sedation, as a day procedure. You will not be admitted overnight in most cases. The surgery itself typically takes between 30 and 60 minutes depending on the procedure. You will need someone to accompany you home.

Immediately After Surgery

The eye will be padded after surgery. Your vision is blurred initially, and the eye may be uncomfortable. This is normal. You will have to use antibiotic and anti-inflammatory drops. These are started immediately, and are essential to the outcome. You may have to continue anti glaucoma eye drops also.

For trabeculectomy patients particularly, the first two to four weeks post-operatively are the most important period. Your doctor monitors eye presssure, bleb appearance, and anterior chamber depth closely. She will also make some ddjustments, including suture lysis or bleb massage, if needed, to optimise outcomes. Missing follow-up appointments in this period is not advisable.

Recovery Timeline

For MIGS combined with cataract surgery, most patients recover within one to two weeks, though drops continue for several weeks.

For trabeculectomy, the functional recovery takes longer, typically four to twelve weeks before vision stabilises and the pressure reaches its longer-term level. The bleb continues to mature over months.

Avoid Strenuous activity, swimming, and rubbing the eyes. This duration is for variable periods depending on the procedure.

Long-Term Follow-Up

Glaucoma surgery is not a cure. It is a pressure-lowering intervention. Your IOP needs to be monitored over the long term. After surgery, regular follow-up continues: OCT, visual fields, and pressure checks to ensure the disease remains stable and to catch any late failure of the surgical intervention early.

Some patients remain completely off drops long-term after trabeculectomy. Others need drops restarted months or years later as the bleb matures or scars. MIGS procedures typically achieve a more modest pressure reduction and many patients continue on reduced medication postoperatively.


Glaucoma Surgery in Gurgaon: What to Look For in a Surgeon

Glaucoma surgery outcomes depend on three things: the right procedure chosen for the right patient, meticulous surgical technique, and careful postoperative management.

For patients considering glaucoma surgery in Gurgaon, the relevant questions to ask are: Has this surgeon performed this specific procedure many times? Do they manage their own postoperative follow-up, or is it handed off? What is their protocol for bleb management after trabeculectomy? What happens if the surgery does not achieve the desired pressure?

Dr Shibal Bhartiya performs the full spectrum of glaucoma surgery in Gurgaon: MIGS, trabeculectomy, tube shunts, and revision surgery for failed prior procedures. She manages all surgical patients through their postoperative course personally and has performed and published on glaucoma surgery outcomes for over two decades.

If you have been told you need glaucoma surgery, or if you are uncertain whether surgery is the right next step, a structured consultation can help. This includes a review of your existing reports, to help you make this decision with clarity.


Frequently Asked Questions

Does glaucoma surgery restore vision?

No. Glaucoma surgery lowers eye pressure to protect the optic nerve from further damage. It does not reverse damage already caused. This is why timing matters, surgery that prevents further loss protects the vision you have.

Is glaucoma surgery painful?

Glaucoma surgery is not painful. Your doctor will choose either topical, local or general anaesthesia. You will experience some discomfort and aching in the first day or two postoperatively. Simple analgesics will help you feel better.

Can glaucoma come back after surgery?

Glaucoma is a lifelong condition. Surgery controls pressure but does not cure the underlying disease. Pressure may rise again over months or years if the surgical drainage pathway scars over, requiring additional intervention. This is why long-term follow-up after surgery is essential.

How long does a trabeculectomy last?

Studies show that trabeculectomy with Mitomycin C achieves adequate pressure control in approximately 70–80% of patients at five years, and in a somewhat lower proportion at ten years. The bleb can be revised if it fails, and additional drops or further surgery can be added if needed.

Can I have glaucoma surgery and cataract surgery at the same time?

Yes, in selected patients. Combined phacoemulsification and MIGS is a well-established approach for patients with mild to moderate glaucoma and concurrent cataract. In patients with more advanced glaucoma, the decision to combine or stage the procedures depends on individual factors. Remember, cataract surgery does not protect you from glaucoma.

What if my prior glaucoma surgery has failed?

Failed blebs can sometimes be rescued with bleb needling and antifibrotics. If not, revision surgery or tube shunt surgery are the next options. This is an area requiring glaucoma specialist expertise, not every glaucoma surgeon manages complex revision cases.

What does glaucoma surgery cost in India?

The cost of glaucoma surgery in India varies significantly depending on the procedure, the hospital, and whether additional procedures such as cataract surgery are being combined. MIGS combined with cataract surgery, trabeculectomy, and tube shunt surgery each have different cost profiles. Within each procedure, factors such as the implant used, antifibrotic agents, anaesthesia type also amke a difference. The length of postoperative follow-up all affect the total cost.

Quoting a cost without a clinical assessment is not meaningful or responsible. The right procedure for your eye is the relevant starting point, and cost follows from that. What matters most is that the surgery chosen is appropriate for your stage of disease. It is performed by a surgeon with subspecialty experience in that specific procedure. Also, a proper follow up, particularly in the critical first weeks after trabeculectomy is mandatory.

To understand what surgery is indicated for your situation and what to expect in terms of process and cost, call +91 88826 38735 to arrange an appointment.


Dr Shibal Bhartiya consults for glaucoma surgery in Gurgaon. For appointments, contact +91 88826 38735. If you are seeking a second opinion before proceeding with surgery, a structured glaucoma second opinion is available.

Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. This article was edited in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

 

Available on Pubmed and Google Scholar

These peer-reviewed articles discussing Glaucoma Surgeries can be accessed on PubMed here, herehere, and here (for MIGS); and here, here, here and here for conventional glaucoma surgeries ( trabeculectomy, NPDS and tubes/ glaucoma shunts)

Consultation Details for Glaucoma Surgery in Gurgaon

www.drshibalbhartiya.com
 +91 88826 38735

Patient reviews Google Business Profile

 

Upload your reports for a structured review.

MIGS: Minimally Invasive Glaucoma Surgery

Minimally Invasive Glaucoma Surgery (MIGS) is a group of surgical procedures designed to lower intraocular pressure using small, precise techniques….

Glaucoma Treatment in Gurgaon

Glaucoma Treatment in Gurgaon: Eye drops, Laser and Surgery Explained by Dr Shibal Bhartiya, a fellowship trained glaucoma specialist.

Glaucoma is a chronic disease. It cannot be cured, but it can be controlled. With the right glaucoma treatment, most patients keep their vision for life. Glaucoma treatment is not one-size-fits-all. The right treatment depends on your glaucoma type, your optic nerve health, your age, your lifestyle, and how fast your disease is progressing. The goal is never just to lower a number, it is to protect the optic nerve over the long arc of your life. This page explains all three treatment options: eye drops, laser, and surgery.

It answers the questions patients most commonly ask about each. If you have been recently diagnosed, or if you are reviewing your current treatment plan, this guide will help you understand your options and what to expect.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care.

Dr Bhartiya performs SLT, laser iridotomy, trabeculectomy, MIGS, and Ahmed Glaucoma Valve implantation, and sees patients from across North India for structured second opinions. She is rated 5 stars across 1,500+ patient reviews on Google. If you have questions about your specific situation, a structured consultation or second opinion can bring clarity.

Unlike a general eye clinic, her consultations focus on individualised target pressure setting, long-term disease trajectory, and treatment decisions that account for your age, lifestyle, and rate of progression: not just your last IOP reading

Q1. I have glaucoma. What are my treatment options?

Your doctor will first perform a test called gonioscopy and other diagnostic tests to determine your glaucoma subtype: open angle or closed angle. This guides all treatment decisions. 

For open-angle glaucoma, treatment usually starts with eye drops to lower eye pressure. Your doctor will monitor their effect over time and adjust as needed. A laser procedure called selective laser trabeculoplasty (SLT) may also be offered, either as a first-line treatment or alongside drops.

For closed-angle glaucoma, a laser procedure called laser peripheral iridotomy (LPI) is the first step. It creates an alternative drainage channel in the iris. Eye drops may be added after.

If drops and laser do not achieve adequate pressure control, particularly in advanced glaucoma or complex subtypes, surgery is recommended. Options include trabeculectomy, minimally invasive glaucoma surgery (MIGS), and tube shunt implants such as the Ahmed Glaucoma Valve.

— Eye Drops —

Q2. What are the common glaucoma medications?

The table below lists the most commonly used glaucoma eye drops. This is not an exhaustive list. Your doctor will prescribe what is most appropriate for your eye pressure, general health, and lifestyle, and customise your glaucoma treatment to best preserve your vision long term.

Class

Drug Name

Action

Half-life

Dosage

Brand Names (India)

Prostaglandin Analogues

Latanoprost

Outflow

Long

Once at bedtime

Xalatan, Latoprost RT

 

Travoprost

Outflow

Long

Once at bedtime

Travatan

 

Bimatoprost

Outflow

Long

Once at bedtime

Lumigan

Beta Blockers

Timolol

Inflow

Moderate

Twice daily

Iotim, Glucomol, Timolol GFS

 

Levobunolol

Inflow

Moderate

Twice daily

Betagan

 

Betaxolol

Inflow

Moderate

Twice daily

Betoptic

Alpha Agonists

Brimonidine

Inflow / Outflow

Moderate

Three times daily

Alphagan

Carbonic Anhydrase Inhibitors

Acetazolamide (tablet)

Inflow

Short

Three times daily / SOS

Diamox, Iopar SR

 

Dorzolamide

Inflow

Shorter

Three times daily

Dorzox

 

Brinzolamide

Inflow

Shorter

Twice daily

Azopt

Miotics

Pilocarpine

Outflow

Short

Three times daily

Pilocarpine

Q3. My eye pressure is normal after medication. Do I still need to take my drops?

Yes, always. Your eye pressure is normal because the drops are working. If you stop, the pressure will rise again within days.

Think of glaucoma like high blood pressure or diabetes. Medication controls the condition; it does not cure it. Stopping glaucoma treatment puts your vision at risk.

Important to Understand: What is my target eye pressure?

Target IOP is the pressure level that will keep your specific optic nerve stable over your lifetime. It is not the same for every patient. Someone with early glaucoma and a healthy nerve may have a target of 18 mmHg. Someone with advanced damage may need a target below 12. Your target is set based on your optic nerve, your rate of progression, your age, and your individual risk. It changes over time as new information comes in.

If your glaucoma continues to progress despite drops, laser or surgery may be the next step.

You can read one of my research papers on this topic, indexed on Pubmed, on New perspectives on target intraocular pressure , which I co-authored with my colleagues from Sydney Eye Hospital, Sydney, Australia; The University of Sydney, Sydney, Australia; and Department of Clinical Neurosciences, University of Geneva, Switzerland.

Q4. Can I switch to a generic medicine?

Generic eye drops contain the same active ingredient at the same concentration, and are chemically equivalent to branded products. In most cases, they are appropriate to use.

However, equivalence in eye drops is harder to guarantee than with tablets, because blood levels cannot be monitored. Small differences in preservatives, drop size, or packaging can affect how well the drop is absorbed and how comfortable it feels.

Discuss any switch with your doctor. If your eye pressures remain stable and the drop is comfortable, a generic may be a reasonable, cost-effective option for glaucoma treatment.

You can read one of my research papers, indexed on Pubmed, on comparative evaluation of pharmaceutical characteristics of three marketed generic vs branded travoprost formulations , which I co-authored with my colleagues from AIIMS, New Delhi which discusses this topic.

Q5. What are the side effects of glaucoma eye drops?

Patients often ask me about Glaucoma Eye Drop Side Effects: What to Expect? Almost all glaucoma drops can cause some eye dryness or local irritation. Allergic reactions are possible with any medication. Specific side effects by drug class include:

  • Prostaglandin Analogues: Darkening of iris or eyelid skin (especially with light eyes), redness, stinging, blurred vision, growth of eyelashes.
  • Beta Blockers: Slowed pulse, fatigue, shortness of breath (particularly in asthma patients), reduced libido, low mood.
  • Alpha Agonists: Stinging, fatigue, headache, drowsiness, dry mouth and nose.
  • Carbonic Anhydrase Inhibitors (eye drop): Stinging, altered taste.
  • Carbonic Anhydrase Inhibitors (oral tablet): Tingling in hands and feet, stomach upset, confusion, low mood, metabolic imbalances.

Note: Preservative Free Glaucoma Eye drops

Most standard glaucoma drops contain a preservative called BAK (benzalkonium chloride). BAK keeps the bottle sterile, but it also irritates the surface of the eye. Used daily for years, it can cause chronic dry eye, redness, and a condition called ocular surface disease.

This matters more than most patients realise. If your eyes are constantly irritated, you are less likely to use your drops consistently. And inconsistent drops mean uncontrolled pressure.

Preservative-free formulations of most common glaucoma medications now exist, including prostaglandins, beta blockers, and fixed combinations. They cost more, but for patients on long-term treatment, or those already prone to dry eye, they are often the right choice.

If your eyes feel persistently dry, red, or irritated on your current drops, tell your doctor. It may not be the medication itself, it may be the preservative. Switching formulation is a simple change that can make a significant difference to both comfort and adherence.

📌 Always tell your doctor if you experience new symptoms. Many side effects can be managed by switching to a different class of drop. A second opinion may help if you are struggling.

Q6. How do I put in my eye drops correctly?

Follow your doctor’s instructions on dose and timing. These steps help ensure the drop reaches the eye and stays in:

  1. Wash your hands before you begin.
  2. Tilt your head back while seated, or lie down.
  3. Gently pull your lower lid down with one finger to form a small pocket.
  4. Look up and squeeze one drop into the pocket. Avoid touching the dropper tip to your eye or hand.
  5. Close your eyes for two minutes. Press gently on the inner corner of the closed eye with your fingertip, this reduces absorption into the bloodstream.
  6. If you use more than one type of drop, wait five minutes between each.
  7. Blot any excess from around the eye with a clean tissue.

📌 If your hands shake, rest your hand against your face and approach from the side. If arthritis makes squeezing difficult, ask your doctor about a bottle-squeezing assistive device.

Q7. I keep forgetting to take my eye drops. What can I do?

You are not alone. Adherence is one of the biggest challenges in glaucoma treatment. Missed drops mean higher pressure and faster disease progression.

Practical strategies that help:

  • Set a recurring alarm on your phone and act on it immediately.
  • Keep your drops on your bedside table and link them to a fixed habit, such as removing your glasses at bedtime. (Note: Xalatan requires refrigeration until opened, after which it can be stored at room temperature.)
  • Download an eye drop reminder app, search ‘eye drop reminder’ on the App Store or Google Play.
  • Ask a family member to remind you, or help you track your drops.
  • Use the same system for scheduling your doctor appointments, a shared calendar or phone reminder works well.

— Laser Treatment —

Q8. I have been advised laser iridotomy. What is that?

A laser peripheral iridotomy (LPI) is used to treat or prevent closed-angle glaucoma. The laser creates a tiny opening in the iris, allowing fluid to flow more freely within the eye and preventing dangerous pressure spikes.

Before the procedure, your doctor will instil drops to make your pupil smaller. A local anaesthetic drop is then applied so you feel no pain. A small lens is placed on your eye to improve visibility, and you are asked to look at a red light while the laser is applied.

Most patients experience mild discomfort, but the procedure is brief. Vision may be blurred for up to three days after. Your doctor will usually prescribe steroid drops for about a week.

Dr Shibal Bhartiya has performed SLT and laser iridotomy in hundreds of patients and integrates laser into the overall treatment strategy based on individual disease profile, not as a reflexive first step.

Q9. I have been advised selective laser trabeculoplasty (SLT). What is that?

SLT is used for open-angle glaucoma. It may be offered as a first option, or in case your glaucoma progresses despite drops. A low-energy laser is applied to the drainage angle of the eye. This stimulates the body’s own immune response to improve fluid outflow and lower eye pressure.

Before the procedure, drops are instilled to constrict the pupil and an eye pressure-lowering agent is given about an hour beforehand. A local anaesthetic drop is applied just before the procedure. You will sit at the laser machine with your face in a chin rest, and a contact lens is placed on the eye, as in a gonioscopy. You may feel a brief twinge or sting as the laser is applied.

Afterwards, you will use anti-inflammatory drops for up to a week. Continue all glaucoma medications as before unless told otherwise. Eye pressure is checked an hour after the procedure and again at one week.

📌 SLT takes one to three months to reach peak effect and may be temporary. Continued follow-up is essential. SLT can often be repeated if the effect wears off.

Not sure whether the surgery recommended for you is the right one? A structured second opinion with Dr Shibal Bhartiya can review your reports and give you clarity

— Surgery —

Q10. What is trabeculectomy? Why might I need it?

Trabeculectomy is the most established glaucoma surgery. It is recommended when eye drops and laser have not adequately controlled your eye pressure, or when glaucoma is advanced at the time of diagnosis.

The surgeon creates a small flap in the white of the eye (sclera) through which fluid can drain out, collecting under the conjunctiva as a small elevation called a bleb. You may be able to see the bleb under your upper eyelid if you look in a mirror.

Trabeculectomy is highly effective in reducing eye pressure, and is the gold standard for surgical glaucoma treatment. It does carry risks, which your doctor will discuss with you before the procedure.

Q11. What is minimally invasive glaucoma surgery (MIGS)?

MIGS is a newer category of glaucoma surgery designed to lower eye pressure with less disruption to the eye than traditional surgery. It is often performed at the same time as cataract surgery.

MIGS procedures include devices such as iStent, Hydrus Microstent, and PRESERFLO MicroShunt. They work by improving drainage through the eye’s natural channels, or by creating a new drainage pathway with less tissue disruption.

MIGS is typically suitable for mild to moderate glaucoma where drops are insufficient or poorly tolerated. It carries a lower risk of complications than trabeculectomy but may produce a more modest pressure reduction.

Dr Shibal Bhartiya offers MIGS as part of a comprehensive glaucoma treatment strategy. If you would like to know whether MIGS is suitable for you, a second opinion consultation can help clarify your options.

Q12. What is an Ahmed Glaucoma Valve?

An Ahmed Glaucoma Valve (AGV) is a small silicone drainage implant placed in the eye to allow fluid to drain to a reservoir under the conjunctiva. It is a type of tube shunt surgery.

Your doctor may also place a small piece of donor sclera (white of the eye) to cover the tube and prevent it from working its way out.

Q13. Why am I getting an Ahmed Valve rather than a trabeculectomy?

Both procedures are proven to be equally effective and safe in the long term. Your doctor will recommend the best option based on your individual history.

An Ahmed Valve is often preferred in the following situations:

  • Previous failed trabeculectomy: a repeat trabeculectomy has a lower chance of success.
  • Certain complex glaucoma subtypes, including inflammatory, neovascular, and post-vitreoretinal surgery glaucomas, or cases with scarred corneas.
  • Your doctor may reserve the Valve as a second-line procedure because of its higher cost.

Q14. What will I feel during surgery?

Surgery sounds frightening. Most patients say the anticipation is far harder than the procedure itself.

Most glaucoma surgeries are performed under local anaesthesia. You will receive an injection around the eye to numb it completely, and an intravenous medication to lower eye pressure before the procedure begins.

You will lie on your back. The area around your eye is cleaned, and a sterile drape is placed over your face. If you feel claustrophobic or are asthmatic, tell your anaesthetist in advance, oxygen can be delivered under the drape.

A small clip keeps the eyelid open so you do not need to worry about blinking. You will see the bright light of the surgical microscope. Your vision will blur as the surgery progresses.

You may feel some pressure or tugging, but surgery is largely painless. Most patients report that the anticipation is worse than the procedure itself. The operation typically takes 45 to 60 minutes. You should be back with family within a couple of hours.

Q15. What is the post glaucoma surgery recovery period like?

Most patients experience a temporary drop in central vision immediately after surgery. This usually recovers within a few weeks. A change in your glasses prescription is common and will be assessed once the eye has stabilised.

Your doctor will see you the day after surgery. You will likely wear an eye patch overnight and have it removed the next morning. Follow-up visits are more frequent in the first few weeks, then become less so as your eye stabilises.

You will be prescribed antibiotic and steroid drops. Some of your glaucoma medications may be continued during the early post-operative period.

Q16. Do I need to restrict activity after surgery?

Gentle walking is encouraged soon after surgery, your doctor will recommend it. For the first week, wear an eye shield at night to protect the eye.

  • Return to desk work: approximately two weeks.
  • Strenuous exercise or weight lifting: avoid for at least one month.
  • Swimming: avoid for at least one month.

📌 Always follow your surgeon’s specific instructions. Recovery timelines can vary depending on the type of surgery and how your eye responds.

Q17. What are the risks of glaucoma surgery?

Your doctor has weighed the risks against the risk of untreated glaucoma progression before recommending surgery. The main risks to be aware of include:

  • Temporary vision drop: Reduced central vision in the early post-operative period due to inflammation, pressure fluctuations, or bleeding. This usually resolves within weeks.
  • Cataract: The risk of cataract development increases after glaucoma surgery, and pre-existing cataract may progress faster.
  • Infection: As with any surgery, there is an increased risk of infection. With trabeculectomy, this risk remains elevated long-term due to the presence of the bleb.
  • Need for additional procedures: A further procedure or surgery may be needed to optimise pressure control.

📌 Knowing the risks allows you to monitor for early signs and report them promptly. Most complications are manageable when caught early.

Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. This article was edited in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Available on Pubmed and Google Scholar

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

Patient reviews Google Business Profile

Upload your reports for a structured review.